Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction

References

• Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003; 349: 1315–23
   PubMed Web of Science ®Google Scholar
• Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation. 2004; 109: 1942–7
   PubMed Web of Science ®Google Scholar
• Silber S, Albertson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European society of cardiology. Eur Heart J. 2005; 26: 804–47
   PubMed Web of Science ®Google Scholar
• Mehta SR, Cannon CP, Fox KA, Wallentin L, Boden WE, Spacek R, et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA. 2005; 293: 2908–17
   PubMed Web of Science ®Google Scholar
• Boersma, E ; The Primary Coronary Angioplasty vs. Thrombolysis (PCAT)-2 Trialist’ Collaborative Group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J. 2006; 27:779–88
   PubMed Web of Science ®Google Scholar
• Valgimigli M, Percoco G, Malagutti P, Campo G, Ferrari F, Barbieri D, et al. Tirofiban and sirolimus-eluting stents vs abciximab and bare-metal stent for acute myocardial infarction. JAMA. 2005; 293: 2109–17
   PubMed Web of Science ®Google Scholar
• Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrie D, et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med. 2006; 355: 1093–104
   PubMed Web of Science ®Google Scholar
• Menichelli M, Parma A, Pucci E, Fiorilli R, De Felice F, Nazzaro M, et al. Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI). J Am Coll Cardiol. 2007; 49: 1924–30
   PubMed Web of Science ®Google Scholar
• Laarman GJ, Suttorp MJ, Dirksen MT, van Heerebeek L, Kiemeneij F, Slagboom T, et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med. 2006; 355: 1105–13
   PubMed Web of Science ®Google Scholar
• Tanimoto S, Tsuchida K, Daemen J, Boersma E. Drug-eluting stent implantation in acute myocardial infarction. Do we need another randomised trial?. EuroIntervention. 2006; 2: 23–7
   PubMedGoogle Scholar
• Pasceri V, Patti G, Speciale G, Pristipino C, Richichi G, Di Sciascio G. Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. Am Heart J. 2007; 153: 749–54
   PubMed Web of Science ®Google Scholar
• Moreno R, Spaulding C, Laarman GJ, Tierala I, Kaiser CA, Lopez-Sendon J-L. Effectiveness and safety of paclitaxel-eluting stents in patients with ST-segment elevation acute myocardial infarction. EuroIntervention. 2007; 3: 386–91
   PubMedGoogle Scholar
• Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J. 2007; 28: 2706–13
   PubMed Web of Science ®Google Scholar
• Terkelsen CJ, Lassen JF, Norgaard BL, Gerdes JC, Jensen T, Gotzsche L, et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J. 2005; 26: 18–26
   PubMed Web of Science ®Google Scholar
• Montalescot G, Dallongeville J, van Belle E, Rouanet S, Baulac C, Degrandsart A, et al. STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). Eur Heart J. 2007; 28: 1409–17
   PubMed Web of Science ®Google Scholar
• Karjalainen P, Ylitalo A, Niemelä M, Kervinen K, Mäkikallio T, Pietilä M, et al. Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: A 12-month follow-up report from the TITAX AMI trial. EuroIntervention. 2008; 4: 232–41
   Google Scholar
• Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice M-C, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007; 356: 998–1008
   PubMed Web of Science ®Google Scholar
• Mauri L, Hsieh W, Massaro JM, Ho K, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007; 356: 1020–9
   PubMed Web of Science ®Google Scholar
• Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, et al. Vascular responses to drug eluting stents. Importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007; 27: 1500–10
   PubMed Web of Science ®Google Scholar
• Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients. Circulation. 2008; 118: 1138–45
   PubMed Web of Science ®Google Scholar
• Windecker S, Simon R, Lins M, Klauss V, Eberli FR, Roffi M, et al. Randomized comparison of a titanium-nitride oxide-coated stent with a stainless steel stent for coronary revascularization. The TINOX trial. Circulation. 2005; 111: 2617–22
   PubMed Web of Science ®Google Scholar
• Karjalainen PP, Ylitalo A, Airaksinen KEJ. Titanium and nitride oxide coated stents and paclitaxel eluting stents for coronary revascularization in an unselected population. J Invasive Cardiol. 2006; 18: 462–8
   PubMedGoogle Scholar
• Karjalainen P, Ylitalo A, Airaksinen KEJ. Real world experience with TITAN® stent: A 9-month follow-up report from the Titan PORI Registry. EuroIntervention. 2006; 2: 187–91
   PubMedGoogle Scholar
• Mosseri M, Miller H, Tamari I, Plich M, Hasin Y, Brizines M, et al. The titanium-NO stent: results of a multicenter registry. EuroIntervention. 2006; 2: 192–6
   PubMedGoogle Scholar
• Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es G-A, et al. Clinical end points in coronary stent trials. A case for standardized definitions. Circulation. 2007; 115: 2344–51
   PubMed Web of Science ®Google Scholar
• Buehl A, Zoefel P. SPSS 11: Introduction in modern data analysis8th ed. Addison-Wesley, MunichGermany 2002
   Google Scholar
• Valgimigli M, Campo G, Arcozzi C, Malagutti P, Carletti R, Ferrari F, et al. Two-years clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa inhibitor infusion in patients with myocardial infarction. Results from the STRATEGY study. J Am Coll Cardiol. 2007; 50: 138–45
   PubMed Web of Science ®Google Scholar
• Dirksen MT, Vink MA, Suttorp MJ, Tijssen JGP, Patterson MS, Slagboom T, et al. Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study. EuroIntervention. 2008; 4: 64–70
   PubMedGoogle Scholar
• Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents. An observational study of drug-eluting versus bare-metal stents (BASKET-LATE). J Am Coll Cardiol. 2006; 48: 2584–91
   PubMed Web of Science ®Google Scholar
• Sianos G, Papafaklis MI, Daemen J, Vaina S, van Mieghem CA, van Domburg RT, et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-elevation myocardial infarction. J Am Coll Cardiol. 2007; 50: 573–83
   PubMed Web of Science ®Google Scholar
• Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?. Circulation. 2004; 109: 701–5
   PubMed Web of Science ®Google Scholar
• Wenaweser P, Daemen J, Zwahlen M, van Domburg R, Juni P, Vaina S, et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. J Am Coll Cardiol. 2008; 52: 1134–40
   PubMed Web of Science ®Google Scholar
• Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007; 369: 667–78
   PubMed Web of Science ®Google Scholar
• Giraud-Sauveur Y. Titan 2 bio-active stent (BAS) with titanium-NO. EuroIntervention. 2007; 3: 526–8
   Google Scholar
• Yeh HI, Lu SK, Tian TY, Hong RC, Lee WH, Tsai CH. Comparison of endothelial cells grown on different stent materials. J Biomed Mater Res. 2006; 76: 835–41
   Google Scholar